Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Waismann Method® Calls for Rapid Detox Safety Standard of Care
  • USA - English


News provided by

AAMOD

Oct 04, 2013, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Michael Lowenstein
Dr. Michael Lowenstein

Beverly Hills, CA (PRWEB) October 04, 2013 -- In response to recent news, including a Centers for Disease Control and Prevention (CDC) report noting severe adverse effects associated with rapid detox programs in New York, Waismann Method® Medical Director Dr. Michael Lowenstein is calling for the creation of universal standards of care for all rapid detoxification treatments to minimize potential risks to patients.

Rapid detox must be performed in an ICU setting, and under the strict supervision of trained medical doctors with appropriate post-treatment monitoring.

Post this

“Unfortunately, rapid detox has become a catch-all term that encompasses a range of unregulated treatments for opiate dependency, leaving patients uneducated about important safety precautions that are vital to their health,” said Dr. Lowenstein. “It’s frightening how many practitioners are not following proper safety protocol and performing rapid detox procedures under sedation or anesthesia as outpatient, leading to increased emergency hospital admissions and deaths. Rapid detox must be performed in an ICU setting, and under the strict supervision of trained medical doctors with appropriate post-treatment monitoring. When done correctly, rapid detox is safe and effective. The key is educating patients on what to look for, and restricting practitioners from cutting corners.”

According to Dr. Lowenstein, the key factors that impact the safety of rapid detox procedures include:

• Medical Screening – All rapid detox patients should undergo a detailed evaluation, including analysis of medical history and a physical examination, laboratory testing, EKG, chest x-ray, and urine toxicology screening. Additional cardiac testing may be required. Admission to the hospital at least one day before a rapid detox procedure affords necessary time to conduct proper medical screening, hydration and pre-medication.
• ICU Setting – Rapid opiate detoxification under sedation can significantly affect the heart, lungs, nervous system, and fluid balance in the body. For these reasons, treatment must take place in an intensive care unit, and patients should be monitored in a hospital or inpatient setting for approximately a day following the procedure so they can be appropriately treated for changes that may arise as a result of the procedure.    
• Anesthesia – General anesthesia is unnecessary for rapid detox, and procedures that place people under for four to eight hours or more can pose great risks to patients. Waismann Method® achieves rapid detoxification using moderate sedation, avoiding general anesthesia and its associated risks.
• Dosage – The procedures under scrutiny in New York used very large doses of Naloxone and Naltrexone to reverse opiate dependence. Waismann Method® utilizes significantly lower doses to safely and effectively rid the body of opiates.
• Post-Procedure Care – Patients who are sent home or to hotel rooms to recover are at much higher risk for serious injury, dehydration, pulmonary/cardiac events and even death, because they don’t have qualified medical professionals to evaluate and treat potential medical emergencies.

Waismann Method®, which pioneered the procedure in 1999, has established a rigorous safety protocol for the treatment of opiate detoxification under sedation. The protocol does not resemble other rapid detox programs performed in New York or other parts of the country that utilize general anesthesia and/or perform the procedure on an outpatient basis through clinics or surgery centers.

“Over the course of 15 years we’ve performed more than 3,000 rapid detox procedures with the Waismann Method®, and we’ve refined the process to maximize the safety and efficacy,” said Dr. Lowenstein. “It’s alarming that patients are being placed in harm’s way because other treatment programs are cutting corners to reduce the cost of the procedure at the expense of patient safety. Patients need to be armed with accurate information to ensure they are getting the highest level of medical attention. It’s time that experts and leaders in the medical community create a specific standard of care for rapid detox, removing the risks associated with unregulated facilities.”

In order to ensure the highest level of safety, all Waismann Method rapid detox treatments are performed in the ICU of an accredited hospital, and patients undergo an extensive medical evaluation prior to treatment. Waismann Method® rapid detox treatment under sedation involves careful administration of medications to reverse the physiological dependence on opiates while the symptoms of withdrawal are addressed.

For more information about Waismann Method® please visit http://www.opiates.com.

About Waismann Method® Treatment
Waismann Method®, directed by Dr. Michael H. Lowenstein, is a pioneering opiate treatment based on a safe and proven protocol that utilizes the most advanced medical techniques available. A major center for opioid dependency, treatment and detoxification based only in California, Waismann Method® offers a variety of programs from rapid opiate detoxification under sedation, to medically assisted detoxification and other forms of treatment at Domus Retreat. Our team of doctors, therapists and staff work with each patient to create personalized treatment and aftercare plans designed to ensure a healthy and effective transition to life without opiates. Patient safety, comfort, and complete confidence are our primary priorities, and we always put treatment and care over blame and punishment. For more information, please visit opiates.com.

Ellen Joy Florendo, AAMOD, 310-205-0808, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.